Programme
| Time | Session |
| 10.00am | LOSIG and GISIG |
| 12.00pm | Lunch (own arrangements) |
| 1.00pm | SIG sessions - open for all NZSO members to attend (details to be confirmed) |
| 2.30pm | Satellite Symposium - Immunotherapy in stage III unresectable lung cancer: From trial to clinic Associate Professor Thomas John sponsored by AstraZeneca |
| 3.30pm | SIG sessions - open for all NZSO members to attend (details to be confirmed) |
| 5.00pm | SIG combined session |
| 6.00pm | Close free evening |
| Time | Session | |
| 7.30am | Registration open | |
| 8.00am | Powhiri | |
| Introducing He Akoranga Whakahoungia (a discipline of re-envisioning) - a new session promoting Māori innovation towards achieving health equity in Oncology | ||
| 10.30am | Morning tea | |
| Novel targeted therapies | ||
| 11.00am | The emerging role of digital pathology and artificial intelligence in oncology David Snead | |
| 11.40am | Gynaecological cancer drivers and therapeutic targets Britta Weigelt | |
| 12.20pm | HIPEC / PIPEC Simi Lolohea | |
| 12.40pm | Lunch | Nurses lunch & BGM |
| Clinical trials | Nurses programme | |
| 1.30pm | Challenging the clinical trial paradigm in New Zealand Michelle Wilson | Voluntary Assisted Dying: What does it mean for nurses? Patsy Yates |
| 1.40pm | Cancer agency update Diana Sarfati | New Zealand end of life bill Jackie Robinson |
| 2.00pm | Teletrials: improving trial outcomes using telehealth. What your neighbours have learnt so far Craig Underhill | Local palliative care |
| 2.30pm | Enhancing drug development through international collaborations Herbert Loong | Panel/debate |
| 3.00pm | International Research / developing countries Bishal Gyawali | |
| 3.30pm | Afternoon tea | |
| Survivorship | ||
| 3.50pm | The fortune and folly of self-diagnosis: an odyssey in the land of small tumours Mark Lewis | |
| 4.30pm | Designing cancer survivorship interventions that improve outcomes for patients and health systems Patsy Yates | |
| Selected oral presentations | ||
| 5.00pm | Disentangling the genomics of small intestinal neuroendicrine tumours Anassuya Ramachandran | |
| 5.10pm | Analysis of breast cancer in young New Zealand women: the Helena McAlpine young women's breast cancer study Annette Lasham | |
| 5.20pm | The physiology of dying Amanda Landers | |
| 5.30pm | Predicting chemotherapy toxicity in older adults - a validation study of the CARG chemo-toxicity calculator in Taranaki, New Zealand Victoria Stiebel | |
| 5.45pm | Poster session, Happy Hour and celebration of Cancer Nurses 25 years | |
| Time | Session |
| 7.00am | Breakfast Symposium Addressing access and applicability in clinical cancer research; a trans-Tasman perspective Dr Miles Andrews and Associate Professor Jonathan Koea sponsored by MSD |
| 8.00am | NZSO AGM Kate Clarke, Chair |
| Translational Research | |
| 9.00am | Understanding and exploiting immune complexity of metastatic breast cancer Karin de Visser |
| 9.40am | Origins of breast cancer / breast cancer risk / breast cancer prevention Kara Britt |
| 10.20am | Attack of the clones: treating oncogene addicted NSCLC Associate Professor Thomas John |
| 10.50am | NZSO Translational Award presentation / lecture |
| 11.25am | Morning tea |
| Pharmac Young Researcher | |
| 11.50am | Pharmac (clinical) : Increased extent of resection improves prognosis for patients with glioblastima in non-eloquent areas Bernard Kim |
| 12.00pm | Pharmac (biomed): Serial detection of tumour-specific mutations in ctDNA for the surveillance of metastatic breast cancer Judy Ann Cocadiz |
| 12.10pm | Pharmac (clinical): Early stage epithelial ovarian cancer in the Auckland region; a retrospective analysis Catherine Bennett |
| 12.20pm | Pharmac (biomed): Investigating the role of TLR2 signalling within 1928T2z CAR T-cells Yasmin Nouri |
| 12.30pm | Pharmac (clinical): The Auckland experience with 177Lu-PSMA-617 in advanced, metastatic castration resistant prostate cancer (mcrpc): 2018-2020 Nadia Hitchen |
| 12.40pm | Pharmac (biomed): Variable expression quantitative trait loci analysis of breast cancer risk variants George Wiggins |
| 12.50pm | Pharmac (clinical): Deficient Mismatch Repair and BRAF mutations in metastatic colorectal cancer in the South Island of New Zealand Jeremy Yaps |
| 1.00pm | Pharmac (Biomed): Rare germline CNVs and endometrial cancer risk Cassie Stylianou |
| 1.10pm | Lunch |
| Selected oral presentations | |
| 2.00pm | Phase 1b/2 KEYNOTE-365 Study of Pembrolizumab Combination Therapies in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC): Cohorts A-c Peter Fong |
| 2.10pm | Molecular profile of endometrial cancer in Aotearoa Claire Henry |
| 2.20pm | Pre-Clinical evaluation of GlycoLipid-Peptide (GLP) conjugate vaccines in breast cancer metastasis models Gavin Painter |
| 2.30pm | Using USPIO-enhanced MRI to distinguish glioblastomas with a high content of tumour associated macrophages Tania Slatter |
| 2.40pm | Tumour and normal tissue radiosensitisation by DNA-PK inhibitors William R Wilson |
| 2.50pm | Pseudokinase Tribbles Homolog 1 more than a passenger of c-MYC amplification in breast cancer Hamish McMillan |
| 3.00pm | Te Oranga Pūkahukahu: Developing a Māori led approach to lung cancer screening Kate Parker |
| 3.10pm | Understanding the molecular basis of a CINister genome: chromosomal instability, metastasis and therapeutic resistance Sunali Mehta |
| 3.20pm | |
| 3.45pm | Bruce Cain Memorial Lecture |
| 4.25pm | Past winner of Roche Translational Award (2020) Rachel Purcell with Tamara Glynn |
| 4.45pm | Close |
| 6.30pm | NZSO Conference Dinner and Awards at Distinction Hotel |